Jeremy M Levin is CEO of Ovid Therapeutics Inc.. Currently has a direct ownership of 3.62 Million shares of OVID, which is worth approximately $3.62 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 18,248 shares (Common Stock) at a price of $2.76 per share, resulting in proceeds of $50,364. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.62M
0% 3M change
0.51% 12M change
Total Value Held $3.62 Million

JEREMY M LEVIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
BUY
Open market or private purchase
$50,364 $2.76 p/Share
18,248 Added 0.5%
3,616,715 Common Stock
Dec 04 2023
SELL
Bona fide gift
-
1,146,550 Reduced 24.16%
3,598,467 Common Stock
JML

Jeremy M Levin

CEO
New York, NY

Track Institutional and Insider Activities on OVID

Follow Ovid Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OVID shares.

Notify only if

Insider Trading

Get notified when an Ovid Therapeutics Inc. insider buys or sells OVID shares.

Notify only if

News

Receive news related to Ovid Therapeutics Inc.

Track Activities on OVID